Heteroaromatic compounds as BTK inhibitors
US9815822B2 · kind B2 · utility
0Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2016 |
| Grant date | Nov 14, 2017 |
| Priority date | — |
| Expiry date | Dec 15, 2036 |
Classification
- Technology area (CPC —)General
Abstract
The present invention encompasses compounds of the formula (I)wherein the groups R1, Cy and Y are defined herein, which are suitable for the treatment of diseases related to BTK, and processes for making these compounds, pharmaceutical preparations containing these compounds, and their methods of use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.